• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉内溶栓的方法学方面。药物、剂量及持续时间。

Methodologic aspects of intracoronary thrombolysis. Drugs, dosage and duration.

作者信息

Cowley M J

出版信息

Circulation. 1983 Aug;68(2 Pt 2):I90-5.

PMID:6222849
Abstract

Clinical experience indicates that the methods of intracoronary thrombolysis are not standardized. Although overall reperfusion rates of 75-80% have been achieved, clinical application at individual centers reflects variations in thrombolytic agents used, dosage, infusion rates, technique of administration and use of adjunctive measures, as well as variation in rates of successful recanalization. Analysis of results as a function of differences in approach suggests that certain procedural factors may influence reperfusion rates. Within the range of total dosage and infusion rates used, higher dosage levels and infusion rates appear to be associated with higher rates of reperfusion. Experimental and preliminary clinical results also suggest that subselective infusion may be associated with higher response rates than ostial infusion of thrombolytic agents. However, additional studies are needed to define the optimal methods of intracoronary thrombolytic therapy.

摘要

临床经验表明,冠状动脉内溶栓方法并不规范。尽管总体再灌注率已达到75% - 80%,但各中心的临床应用情况显示,在溶栓药物的使用、剂量、输注速率、给药技术及辅助措施的使用方面存在差异,成功再通率也有所不同。根据治疗方法差异对结果进行分析表明,某些操作因素可能会影响再灌注率。在所用总剂量和输注速率范围内,较高的剂量水平和输注速率似乎与更高的再灌注率相关。实验和初步临床结果还表明,与在冠状动脉开口处输注溶栓药物相比,选择性亚组输注可能有更高的反应率。然而,还需要进一步研究来确定冠状动脉内溶栓治疗的最佳方法。

相似文献

1
Methodologic aspects of intracoronary thrombolysis. Drugs, dosage and duration.冠状动脉内溶栓的方法学方面。药物、剂量及持续时间。
Circulation. 1983 Aug;68(2 Pt 2):I90-5.
2
Regional and systemic thrombolytic therapy in acute myocardial infarction.
Cardiovasc Clin. 1984;14(3):235-45.
3
[Intracoronary thrombolytic therapy of acute myocardial infarction].[急性心肌梗死的冠状动脉内溶栓治疗]
Grudn Khir. 1985 Sep-Oct(5):58-65.
4
Coronary thrombolysis for evolving myocardial infarction.进展性心肌梗死的冠状动脉溶栓治疗。
Drugs. 1984 Nov;28(5):465-83. doi: 10.2165/00003495-198428050-00004.
5
Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.
Thromb Haemost. 1983 Dec 30;50(4):792-6.
6
Indications for and limitations of coronary thrombolysis.冠状动脉溶栓的适应证与局限性
Jpn Circ J. 1985 Jun;49(6):597-604. doi: 10.1253/jcj.49.597.
7
[Administration of thrombolytic mixtures by superselective catheterization of the affected coronary artery for thrombolysis in acute myocardial infarct].通过对受累冠状动脉进行超选择性导管插入术给药溶栓混合物用于急性心肌梗死溶栓治疗
Vestn Akad Med Nauk SSSR. 1981(10):63-7.
8
[New methods of thrombolysis].
Wien Med Wochenschr. 1987 Jun 15;137(10-11):221-4.
9
An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.外周和冠状动脉血栓形成的局部与全身溶栓治疗评估。
Prog Hemost Thromb. 1984;7:325-56.
10
[Intracoronary thrombolysis].[冠状动脉内溶栓]
G Ital Cardiol. 1983;13(4):345-8.